US Pharma Key to Proteros’ Plan to Expand Core Protein-Analysis Business | GenomeWeb
With a shift in focus toward markets abroad, especially the US, Germany-based protein-structure analysis firm Proteros is looking to build on its core business and expand into new ones.
For most of its history, the firm had put most of its eggs in the European pharmaceutical and biotech basket. But about a year ago, realizing it would have to adopt a more global perspective to continue growing, it upped its efforts to add clients overseas.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.